http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101472944-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate | 2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101472944-B1 |
| titleOfInvention | 2',2-bisthiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
| abstract | The present invention relates to a class of 2 ', 2-bistiazolone nucleoside compounds of formula (I), a process for their preparation, and pharmaceutical compositions containing them, belonging to pharmacy. The compounds have both anti-HBV and anti-HCV activity and are useful for the treatment of hepatitis B and C hepatitis. Pharmacokinetic studies have shown that the compounds have excellent bioactivity. |
| priorityDate | 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.